ArticleJournal of orthopaedic surgery and research2025
Cost-effectiveness of total knee arthroplasty, unicompartmental knee arthroplasty, and high tibial osteotomy for medial compartment knee osteoarthritis in young patients: a Canadian public payer perspective.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond the Surgical Bill: Pharmacoeconomics and Real-World Utilization Across the Knee Osteoarthritis Care Pathway-A Critical Narrative Review.Healthcare (Basel, Switzerland) · 2026Review
- Beyond conversion to TKA: selective tibial component revision for failed medial UKA (case report).International journal of surgery case reports · 2026Article
- Portable electronic devices for mechanotherapy and operative treatment of osteoarthritis.Mechanobiology in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn medial compartment osteoarthritis (OA) of the knee in young patients who fail conservative treatment, clinical equipoise exists between three surgical strategies: (1) total knee arthroplasty (TKA), (2) unicompartmental knee arthroplasty (UKA), and (3) medial opening wedge high tibial osteotomy (HTO). This study evaluated the cost-effectiveness of three surgical strategies, using a probabilistic Markov model from the Ontario public payer perspective in Canada.
methodsA probabilistic Markov model was developed to perform a cost-utility analysis comparing TKA, UKA, and HTO. The base case simulated a 45-year-old Canadian cohort with unilateral medial knee OA over a lifetime horizon. Outcomes included quality-adjusted life months (QALMs), discounted lifetime costs (1.5% annually), incremental cost-effectiveness ratios (ICERs), and net monetary benefit (NMB), reported in 2023 Canadian dollars (CAD, $). A willingness to pay (WTP) threshold of $4,166.67/QALM was applied. Model uncertainty was assessed via 3,000 iterations of probabilistic sensitivity analysis. Scenario analyses using sex-specific mortality rates were also conducted.
resultsMean costs were $9,157 (TKA), $9,238 (HTO), and $9,419 (UKA). UKA produced the highest QALMs (290.53), followed by TKA (277.02) and HTO (270.88). HTO was absolutely dominated, as it was both more costly and less effective than TKA. Among undominated strategies, UKA yielded an ICER of $19.46/QALM compared to TKA. UKA also had the highest NMB ($1,201,112), outperforming TKA ($1,145,110) and HTO ($1,119,411). UKA was the most cost-effective option in 55.27% of probabilistic simulations, followed by TKA (23.83%) and HTO (20.90%). Scenario analyses with sex-specific mortality showed similar trends.
conclusionsUKA is the most cost-effective surgical strategy from a public payer perspective for young patients with medial knee OA. At a WTP of $4,166.67/QALM, UKA balances long-term durability and economic value better than TKA or HTO. LEVEL OF EVIDENCE: Level III, Model-based economic evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.